Evidence map›Paper›PMID 28580185›Full record

ArticleAging and disease2017

The Soluble VEGF Receptor sFlt-1 Contributes to Impaired Neovascularization in Aged Mice.

Guangxian Zhao, Xian W Cheng, Limei Piao, Lina Hu, Yanna Lei, Guang Yang, Aiko Inoue, Shinyu Ogasawara, Hongxian Wu, Chang-Ning Hao and 2 more

Open access · goldAbstract read
In one paragraph

Article in Aging and disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. New perspectives on VEGF signalling in Alzheimer's disease.Brain pathology (Zurich, Switzerland) · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Guangxian Zhao1Department of Cardiology, Yanbian University Hospital, Yanji, Jilin 133000, China.
Xian W Cheng1Department of Cardiology, Yanbian University Hospital, Yanji, Jilin 133000, China.
Limei Piao1Department of Cardiology, Yanbian University Hospital, Yanji, Jilin 133000, China.
Lina Hu3Department of Public Health, Guilin Medical College, Guilin, Guangxi 541004, China.
Yanna Lei1Department of Cardiology, Yanbian University Hospital, Yanji, Jilin 133000, China.
Guang Yang1Department of Cardiology, Yanbian University Hospital, Yanji, Jilin 133000, China.
Aiko Inoue2Department of Health Care & Geriatrics, Nagoya University Graduate School of Medicine, Aichiken 4668550, Japan.
Shinyu Ogasawara2Department of Health Care & Geriatrics, Nagoya University Graduate School of Medicine, Aichiken 4668550, Japan.
Hongxian Wu4Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 20160527, China.
Chang-Ning Hao5Department of vascular surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200126, China.
Kenji Okumura6Department of Cardiology, Tohno Kosei Hospital, Mizunai, Japan.
Masafumi Kuzuya3Department of Public Health, Guilin Medical College, Guilin, Guangxi 541004, China.
Nagoya University · JPYanbian University Hospital · CNShanghai First People's Hospital · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mechanism by which angiogenesis declines with aging is not fully understood. Soluble vascular endothelial growth factor receptor 1 (VEGFR1) form (sFlt1) contributes to endothelial dysfunction in pathological conditions. However, the roles of sFlt1 in ischemia-induced neovascularizationof aged animals have not been investigated. To study aging-related sFlt1 change and its impact on ischemia-induced neovascularization, a hindlimb ischemia model was applied to young and aged mice. Blood flow imaging assay revealed that the blood flow recovery remained impaired throughout the follow-up period. At day 14, immunostaining showed lesser capillary formation in the aged mice. An ELISA showed that the aged mice had increased plasma sFlt-1 levels at indicated time points after surgery. On operative day 4, the aged ischemic muscles had decreased levels of p-VEGFR2 and p-Akt and increased levels of sFlt-1, Wnt5a, and SC35 genes or/and protein as well as increased numbers of inflammatory cells (macrophages and leucocytes) and matrix metalloproteinase-9 activity. Immnunofluorescence showed that Flt-1 was co-localized with CD11b

Indexed as

agingangiogenesisperipheral arterial diseasesoluble Flt1Wnt5

Identifiers

PMID28580185
PMCPMC5440109
OpenAlexW2617878584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.